Program in Physical and Occupational Therapy, Nagoya University Graduate School of Medicine, Nagoya, Japan.
J Cardiol. 2012 Nov;60(5):411-5. doi: 10.1016/j.jjcc.2012.07.009. Epub 2012 Aug 13.
We aimed to verify a measure for functional limitation using the Performance Measure for Activity of Daily Living-8 (PMADL-8) clinical assessment tool. This tool was utilized to determine disease severity by comparing disease severity with physiological and demographic variables, which have been well documented as predictors for mortality and rehospitalization in chronic heart failure (CHF) patients.
We consecutively enrolled 125 CHF patients with impaired left ventricular systolic function who underwent cardiopulmonary exercise testing in Nagoya University Hospital. We measured PMADL-8, which had a total score that ranged from 8 to 32 points, in which higher scores indicated severe functional limitations to evaluate the patient's functional limitations and evaluate clinical physiologic variables, which were established as prognostic factors of CHF. First, the association between PMADL-8 and other clinical variables was analyzed by correlation coefficients, and then, multivariate regression analysis was performed to select independent correlate factors. Lastly, we identified the optimal PMADL-8 threshold for detecting disease severity by comparing with the threshold for disease severity in selected variables.
The PMADL-8 indicated excellent correlation with peak oxygen uptake (peakVO(2)) (r=-0.743, p<0.001), and the multivariate regression analysis revealed that peakVO(2) was independently correlated with the PMADL-8 (p<0.001). The optimal PMADL-8 threshold for detecting a peakVO(2) value of 18 ml/min/kg was 18 points. Similarly, a peakVO(2) value of 14 ml/min/kg was 22 points, and a peakVO(2) value of 16 ml/min/kg was 20 points.
Our data indicate that functional limitation as evaluated by the PMADL-8 is well correlated with peakVO(2). PMADL-8 may have potential as a clinical assessment tool to manage disease status in CHF patients.
我们旨在验证使用日常生活活动能力量表-8(PMADL-8)临床评估工具来衡量功能障碍的方法。该工具通过将疾病严重程度与生理和人口统计学变量进行比较来确定疾病严重程度,这些变量已被很好地记录为慢性心力衰竭(CHF)患者死亡和再住院的预测因素。
我们连续纳入了 125 名在名古屋大学医院接受心肺运动测试的左心室收缩功能受损的 CHF 患者。我们测量了 PMADL-8,其总分为 8 至 32 分,得分越高表示严重的功能障碍,以评估患者的功能障碍,并评估临床生理变量,这些变量已被确立为 CHF 的预后因素。首先,通过相关系数分析 PMADL-8 与其他临床变量之间的关系,然后进行多元回归分析以选择独立相关因素。最后,我们通过与选定变量的疾病严重程度阈值进行比较,确定了检测疾病严重程度的最佳 PMADL-8 阈值。
PMADL-8 与峰值摄氧量(peakVO2)(r=-0.743,p<0.001)呈极好的相关性,多元回归分析显示 peakVO2 与 PMADL-8 独立相关(p<0.001)。检测 peakVO2 值为 18 ml/min/kg 的最佳 PMADL-8 阈值为 18 分。同样,peakVO2 值为 14 ml/min/kg 的为 22 分,peakVO2 值为 16 ml/min/kg 的为 20 分。
我们的数据表明,PMADL-8 评估的功能障碍与 peakVO2 密切相关。PMADL-8 可能有潜力成为管理 CHF 患者疾病状态的临床评估工具。